AG006YAK

49745-95-1 | 1,2-Benzenediol, 4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-, hydrochloride (1:1)

Chemical structure of 1,2-Benzenediol, 4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-, hydrochloride (1:1), CAS 49745-95-1
AG006YAK
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 49745-95-1
Catalog Number AG006YAK(AGN-PC-0S4N8N)
Chemical Name 1,2-Benzenediol, 4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-, hydrochloride (1:1)
EC Number 256-464-1
IUPAC Name 4-[2-[4-(4-hydroxyphenyl)butan-2-ylamino]ethyl]benzene-1,2-diol;hydrochloride
InChI InChI=1S/C18H23NO3.ClH/c1-13(2-3-14-4-7-16(20)8-5-14)19-11-10-15-6-9-17(21)18(22)12-15;/h4-9,12-13,19-22H,2-3,10-11H2,1H3;1H
InChI Key BQKADKWNRWCIJL-UHFFFAOYSA-N
MDL Number MFCD00153795
Molecular Formula C18H24ClNO3
Molecular Weight 337.8411
NSC Number 299583
SMILES OC1=CC=C(CCNC(C)CCC2=CC=C(O)C=C2)C=C1O.[H]Cl
Synonyms
Dobucor, Dobuject, Dobutamin Fresenius, Dobutamin Hexal, Dobutamin ratiopharm, Dobutamin Solvay, Dobutamin-ratiopharm, Dobutamina Inibsa, Dobutamina Rovi, Dobutamine, Dobutamine (+)-Isomer, Dobutamine Hydrobromide, Dobutamine Hydrochloride, Dobutamine Lactobionate, Dobutamine Phosphate (1:1) Salt, (-)-Isomer, Dobutamine Tartrate, Dobutamine Tartrate (1:1), (R-(R*,R*))-Isomer, Dobutamine Tartrate (1:1), (S-(R*,R*))-Isomer, Dobutamine, (-)-Isomer, Dobutamine, Phosphate (1:1) Salt (+)-Isomer, Dobutrex, Hydrobromide, Dobutamine, Hydrochloride, Dobutamine, Lactobionate, Dobutamine, Lilly 81929, Oxiken, Posiject, Tartrate, Dobutamine, Dobutamine hydrochloride, 49745-95-1, Dobutamine Hcl, Dobutrex, Inotrex, Dobutamine (hydrochloride), DL-Dobutamine hydrochloride, 52663-81-7, Dobutamina clorhidrato [Spanish], EINECS 256-464-1, NSC 299583, LY 46236, S-1000, MFCD00153795, 4-[2-[4-(4-hydroxyphenyl)butan-2-ylamino]ethyl]benzene-1,2-diol hydrochloride, (+-)-4-(2-((3-(p-Hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol hydrochloride, 1,2-Benzenediol, 4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-, hydrochloride (1:1), 1,2-Benzenediol, 4-(2-((3-(4-hydroxyphenyl)-1-methylpropyl)amino)ethyl)-, hydrochloride, (+-)-, W-106009, CHEBI:4671, Dobutamine Hcl in Dextrose 5%, (+/-)-3,4-Dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-beta-phenethylamine hydrochloride, 4-(2-((3-(p-Hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatecholhydrochloride, SMR000058435, SR-01000075265, DOBUTAMINEHYDROCHLORIDE, Posiject, 4-(2-(4-(4-hydroxyphenyl)butan-2-ylamino)ethyl)benzene-1,2-diol hydrochloride, Dobutrex (TN), Prestwick_741, Dobutamine hydrochloride in dextrose 5%, Dobutamine hydrochloride [USAN:BAN:JAN], 1,2-Benzenediol, 4-(2-((3-(4-hydroxyphenyl)-1-methylpropyl)amino)ethyl)-, hydrochloride, 4-(2-{[4-(4-hydroxyphenyl)butan-2-yl]amino}ethyl)benzene-1,2-diol hydrochloride, Dobutamine hydrochloride [USAN:USP:BAN:JAN], AC1Q3F7E, rac Dobutamine Hydrochloride, SCHEMBL41609, MLS000860012, MLS001332503, MLS001332504, MLS002222253, REGID_for_CID_65324, AC1L231V, CHEMBL1200418, CTK1D5917, BQKADKWNRWCIJL-UHFFFAOYSA-N, Dobutamine hydrochloride, >=98%, Dobutamine hydrochloride in dextrose 5% in plastic container, HMS1569G05, BCP13026, KS-000016OW, Tox21_500365, BG0171, NSC299583, Dobutamine hydrochloride (JP17/USP), AKOS015907731, AN-6582, CCG-220352, CCG-221669, CHM0029387, CS-3099, KS-1050, LP00365, NSC-299583, NCGC00093799-01, NCGC00093799-02, NCGC00261050-01, AC-11653, BC202981, CC-27337, HY-15746, LS-29983, LY-46236, Q711, AB0017762, AB1009505, AX8016940, LS-175120, TR-036978, D4335, EU-0100365, FT-0625557, FT-0681170, D 0676, D00632, 368D042, A827836, I14-2722, SR-01000075265-1, SR-01000075265-3, SR-01000075265-6, DOBUTAMINE HCL IN DEXTROSE 5% IN PLASTIC CONTAINER, Dobutamine hydrochloride, British Pharmacopoeia (BP) Reference Standard, Dobutamine hydrochloride, European Pharmacopoeia (EP) Reference Standard, (.+-.)-4-[2-[[3-(p-Hydroxyphenyl)-1-methylpropyl]amino]ethyl]pyrocatechol hydrochloride, 1, 4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-, hydrochloride, (.+-.)-, 3,4-Dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-beta-phenethylamine Hydrochloride, 4-(2-{[3-(4-hydroxyphenyl)-1-methylpropyl]amino}ethyl)benzol-1,2-diolhydrochlorid, 4-[2-[[3-(4-hydroxyphenyl)-1-methyl-propyl]amino]ethyl]benzene-1,2-diol hydrochloride, 4-[2-[[3-(4-Hydroxyphenyl)-1-methylpropyl]amino]ethyl]-1,2-benzenediol hydrochloride, 4-[2-[[3-(4-Hydroxyphenyl)-1-methylpropyl]aminoethyl-1,2-benzenediol hydrochloride, 4-[2-[4-(4-hydroxyphenyl)butan-2-ylamino]ethyl]benzene-1,2-diol;hydrochloride, Dobutamine hydrochloride, United States Pharmacopeia (USP) Reference Standard, ( inverted exclamation markA)-3,4-Dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-|A-phenethylamine hydrochloride; 4-[2-[[3-(4-Hydroxyphenyl)-1-methylpropyl]amino]ethyl]-1,2-benzenediol hydrochloride, ( inverted question mark)-4-[2-[[3-(4-Hydroxyphenyl)-1-methylpropyl]amino]ethyl]-1,2-benzenediol hydrochloride, 1,2-Benzenediol, 4-(2-((3-(4-hydroxyphenyl)-1-methylpropyl)amino)ethyl)-, hydrochloride,(+-)-, dobutamine, Dobutamina clorhidrato, UNII-0WR771DJXV, 0WR771DJXV, C18H24ClNO3, C18H23NO3.ClH, C18H23NO3.HCl, C18H23NO3 X ClH, C18-H23-N-O3.x-Cl-H, CID65324, ACN-038321, LY 81929, 49745-95-1 (HCl), C(CNC(C)CCc1ccc(O)cc1)c2ccc(O)c(O)c2, Dobutamine hydrochloride, 98% - 10MG 10mg, 1,2-Benzenediol, 4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-, hydrochloride, 12-Benzenediol 4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-hydrochloride (9CI), 4-[2-[[3-(p-hydroxyphenyl)-1-methylpropyl]amino]ethyl]pyrocatechol hydrochloride, ] 1,2-benzenediol, 4-[2-[[3-(4-hidroxifenil)-1-amino metilpropil] etil]-,clorhidrato de (9CI), 1 2-Benzenediol 4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-hydrochloride (9CI), 1,2-benzenediol, 4-[2-[[3-(4-hidroxifenil)-1-metilpropil] amino] etil]-, clorhidrato (1:1), 1,2-Benzenediol, 4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-, hydrochloride, (.+.)-, 34368-04-2, HCl,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited